000
| 01667nas 2200289za 4500 |
---|
001 | 9.506581 |
---|
003 | CaOODSP |
---|
005 | 20221107133644 |
---|
007 | cr ||||||||||| |
---|
008 | 150406d20052016oncar p o||||f0 a0eng|d |
---|
022 | |a2368-1063 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH79-2E-PDF |
---|
110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
---|
245 | 10|aDepartmental performance report |h[electronic resource] / |cPatented Medicine Prices Review Board. |
---|
260 | |aOttawa : |bPatented Medicine Prices Review Board, |c[2005-2016] |
---|
310 | |aAnnual |
---|
362 | 1 |aBegan with 2004/2005 ; ceased with 2015/2016. |
---|
500 | |aIssued also in French under title: Rapport ministériel sur le rendement. |
---|
515 | |aReport year ends Mar. 31. |
---|
520 | 3 |aDepartmental Performance Reports are part of the Estimates prepared by the Government of Canada each year in support of its request to Parliament for authority to spend public monies. Each report emphasizes accountability, comparing accomplishments with the expectations and commitments set out earlier in the department’s Report on Plans and Priorities. The Departmental Performance Reports reflect the citizen focus of government programs, setting out the strategic context, the risks and challenges to meeting commitments, and the links between resources the department uses and the benefits it has achieved for Canadians and Canadian society. |
---|
692 | 07|2gccst|aDrugs |
---|
692 | 07|2gccst|aPrices |
---|
692 | 07|2gccst|aPerformance assessment |
---|
775 | 08|tRapport ministériel sur le rendement |w(CaOODSP)9.502976 |
---|
785 | 00|tDepartmental results report |w(CaOODSP)9.839476 |
---|